This bill proposes the repeal of RSA 126-Q, which pertains to the New Hampshire Vaccine Association (NHVA). The repeal will eliminate the NHVA's role in collecting payments from approximately 80 commercial payers and third-party administrators, which are currently used to reimburse the Department of Health and Human Services for the non-governmental share of the state's universal vaccine purchasing program for children. As a result of this repeal, the state anticipates a decrease in revenue of approximately $24 million annually, which will also correspond to a decrease in state expenditures by the same amount. The Department of Health and Human Services will need to hire a temporary part-time position to manage the transition, incurring additional costs.

The bill does not authorize new funding or positions, but it is expected to lead to increased insurance premium tax revenue due to potential increases in healthcare costs for insurers. Without the NHVA, health insurers may lose access to significant savings on vaccine costs, which could result in higher premiums and increased administrative expenses as they would need to process claims for childhood vaccines. The bill is set to take effect 60 days after its passage.